Taysha Gene Therapies
TSHA
#6686
Rank
A$0.77 B
Marketcap
$3.78
Share price
13.30%
Change (1 day)
31.49%
Change (1 year)

Earnings for Taysha Gene Therapies (TSHA)

Earnings in 2024 (TTM): -A$0.19 Billion

According to Taysha Gene Therapies's latest financial reports the company's current earnings are A$12.87 Million. In 2023 the company made an earning of -A$0.18 Billion, an increase over its 2022 earnings that were of -A$0.26 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Taysha Gene Therapies from 2020 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$0.19 Billion5.69%
2023 -A$0.18 Billion-33.06%
2022 -A$0.26 Billion-4.51%
2021 -A$0.27 Billion190.82%
2020 -A$91.75 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.2 Billion 9.43%๐Ÿ‡บ๐Ÿ‡ธ USA